# Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices

> **NCT02856646** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 290 (actual)

## Conditions studied

- Hodgkin's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02856646
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-07
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2021-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02856646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02856646, "Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02856646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*